WHO ICTRP trial

Duration of luteal support with progesterone pessaries to improve the success…

ISRCTN05696887 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN05696887
Public title Duration of luteal support with progesterone pessaries to improve the success rates in assisted conception
Scientific title Duration of Luteal Support with progesterone pessaries to improve the success rates in assisted conception: a randomised controlled trial
Primary sponsor Liverpool Women's NHS Foundation Trust (UK)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries United Kingdom;England
Conditions Infertilty Pregnancy and Childbirth Female infertility
Interventions Patients will be randomised to two groups of treatments: Group A: Active drug. Cyclogest, Actavis UK PL00142/05/08. One pessary (400mg) vaginally or rectally twice daily for 8 weeks following positive pregnancy test. Group B: Placebo…
Registration date Mar 26, 2012
Target size 460
Secondary IDs 2006-000599-33;EudraCT 2006-000599-33
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations